Sandra K. Althouse

Treatment variables related to liver toxicity in patients with hepatocellular carcinoma, Child-Pugh class A and B enrolled in a phase 1-2 trial of stereotactic body radiation therapy

Foster D. Lasley, Edward M. Mannina, Cynthia S. Johnson et al. · Practical Radiation Oncology · 2015 · 188 citations

Treatment Variables, Radiation Medicine, Hepatology +11

Phase II trial of pembrolizumab in patients with platinum refractory germ-cell tumors: a Hoosier Cancer Research Network Study GU14-206

Nabil Adra, Lawrence H. Einhorn, Sandra K. Althouse et al. · Annals of Oncology · 2017 · 185 citations

Urology, Phase Ii Trial, Medicine +5

High-Dose Chemotherapy and Autologous Peripheral-Blood Stem-Cell Transplantation for Relapsed Metastatic Germ Cell Tumors: The Indiana University Experience

Nabil Adra, Rafat Abonour, Sandra K. Althouse et al. · Journal of Clinical Oncology · 2017 · 167 citations · Full text

A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non–small cell lung cancer: Hoosier Cancer Research Network LUN 14‐179

Greg Andrew Durm, Salma K. Jabbour, Sandra K. Althouse et al. · Cancer · 2020 · 158 citations · Full text

A single-cell atlas of the healthy breast tissues reveals clinically relevant clusters of breast epithelial cells

Poornima Bhat‐Nakshatri, Hongyu Gao, Sheng Liu et al. · Cell Reports Medicine · 2021 · 115 citations · Full text